Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Itching; Runny nose; Hay fever; This is a spontaneous report from a contactable consumer received from the Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202106021139475190-ECHE9. Safety Report Unique Identifier: GB-MHRA-ADR 25404444. A 33-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 01Jun2021 (Batch/Lot number was not reported) at the age of 33 years old, single dose, for Covid-19 immunisation. Medical history included lactation decreased. Patient has not tested positive for COVID-19 since having the vaccine. Patient has not had symptoms associated with COVID-19; not had a COVID-19 test. Patient was not enrolled in clinical trial. Patient was not pregnant at the time of vaccination. Patient was not currently breastfeeding. The patient''s concomitant medications were not reported. The patient experienced runny nose, and hay fever on 01Jun2021; itching on 02Jun2021. The events were reported as medically significant. Outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166